Ethical Compliance
IND SWIFT LABORATORIES LT
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
small
Revenue
3.4%
Debt
1.4%
Liquidity
14.5%
Revenue
Debt
Liquidity
3.4%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Revenue From Operations | ₹1,280.90 |
Questionable
INR Crores
| Other Income | ₹26.99 |
Non Compliant
INR Crores
| Interest Income | ₹18.37 |
INR Crores
| Revenue from Questionable Sources: | ₹26.99 |
| Revenue from Non Compliant Sources: | ₹18.37 |
| Total: | ₹45.37 |
| Total Revenue: | ₹1,326.27 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹45.37
₹1,326.27
= 3.4%
questionable
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
